Literature DB >> 27102765

IgM antibodies against malondialdehyde and phosphorylcholine are together strong protection markers for atherosclerosis in systemic lupus erythematosus: Regulation and underlying mechanisms.

Mizanur Rahman1, Sudhir Sing1, Zahra Golabkesh1, Roland Fiskesund1, Thomas Gustafsson2, Tomas Jogestrand2, Anna G Frostegård1, Ingiäld Hafström3, Anquan Liu1, Johan Frostegård4.   

Abstract

OBJECTIVES: Phosphorylcholine (PC) and malondialdehyde (MDA) are generated during lipid peroxidation and form adducts with proteins as albumin as studied herein. Atherosclerosis and cardiovascular disease (CVD) are increased in systemic lupus erythematosus (SLE). We here investigate the role and regulation of IgM antibodies against PC (anti-PC) and MDA (anti-MDA).
METHODS: IgM anti-PC and anti-MDA in SLE patients (n=114) were compared with age- and sex-matched population-based controls (n=108). Common carotid intima-media thickness (IMT) and plaque occurrence were determined by B-mode ultrasound. Plaques were graded according to echogenicity (potentially vulnerability). Production of IgM anti-PC and anti-MDA by B cells was determined by ELISA and ELISPOT. The effect of anti-PC and anti-MDA on macrophage uptake of apoptotic cells and oxidative stress was studied by flow cytometry.
RESULTS: Above 66rd percentile together, IgM anti-PC and anti-MDA were striking protection markers for plaque prevalence and echolucency in SLE (OR: 0.08, CI: 0.01-0.46 and OR: 0.10, CI: 0.01-0.82), respectively, and risk markers for plaque prevalence when below 33rd percentile: OR: 3.79, CI: (1.10-13.00). In vitro, IgM anti-PC and anti-MDA were much higher when B cells were co-cultured with CD3 T cells. Anti-HLA-, anti-CD40 antibody or CD40 silencing abolished these effects. Uptake of apoptotic cells was increased by IgM anti-PC and anti-MDA. MDA induced increased oxidative stress, which was inhibited by IgM anti-MDA.
CONCLUSIONS: Unexpectedly, both IgM anti-MDA and IgM anti-PC are T-cell dependent and especially together, are strong protection markers for atherosclerosis in SLE. Underlying mechanisms include increased phagocytosis of apoptotic cells and decrease of oxidative stress.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibodies; Atherosclerosis; Malondialdehyde; Phosphorylcholine; Systemic lupus erythematosus; T-cells; Vulnerable plaque

Mesh:

Substances:

Year:  2016        PMID: 27102765     DOI: 10.1016/j.clim.2016.04.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  25 in total

Review 1.  Metabolic abnormalities and oxidative stress in lupus.

Authors:  Yaima L Lightfoot; Luz P Blanco; Mariana J Kaplan
Journal:  Curr Opin Rheumatol       Date:  2017-09       Impact factor: 5.006

2.  Autoimmunity: Do IgM antibodies protect against atherosclerosis in SLE?

Authors:  Maureen McMahon; Brian Skaggs
Journal:  Nat Rev Rheumatol       Date:  2016-06-30       Impact factor: 20.543

3.  IgM-mediated autoimmune responses to oxidative specific epitopes, but not nitrosylated adducts, are significantly decreased in pregnancy: association with bacterial translocation, perinatal and lifetime major depression and the tryptophan catabolite (TRYCAT) pathway.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-06-09       Impact factor: 3.584

Review 4.  Cardiovascular disease in systemic lupus erythematosus.

Authors:  Maureen McMahon; Richard Seto; Brian J Skaggs
Journal:  Rheumatol Immunol Res       Date:  2021-12-15

5.  A genome-wide association study of IgM antibody against phosphorylcholine: shared genetics and phenotypic relationship to chronic lymphocytic leukemia.

Authors:  Xu Chen; Stefan Gustafsson; Thomas Whitington; Yan Borné; Erik Lorentzen; Jitong Sun; Peter Almgren; Jun Su; Robert Karlsson; Jie Song; Yi Lu; Yiqiang Zhan; Sara Hägg; Per Svensson; Karin E Smedby; Susan L Slager; Erik Ingelsson; Cecilia M Lindgren; Andrew P Morris; Olle Melander; Thomas Karlsson; Ulf de Faire; Kenneth Caidahl; Gunnar Engström; Lars Lind; Mikael C I Karlsson; Nancy L Pedersen; Johan Frostegård; Patrik K E Magnusson
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

Review 6.  Musculoskeletal involvement and ultrasonography update in systemic lupus erythematosus: New insights and review.

Authors:  Vicenç Torrente-Segarra; Tarek Carlos Salman Monte; Hèctor Corominas
Journal:  Eur J Rheumatol       Date:  2018-07

7.  Human IgM Antibodies to Malondialdehyde Conjugated With Albumin Are Negatively Associated With Cardiovascular Disease Among 60-Year-Olds.

Authors:  Divya Thiagarajan; Anna G Frostegård; Sudhir Singh; Mizanur Rahman; Anquan Liu; Max Vikström; Karin Leander; Bruna Gigante; Mai-Lis Hellenius; Bo Zhang; Roman A Zubarev; Ulf de Faire; Susanna L Lundström; Johan Frostegård
Journal:  J Am Heart Assoc       Date:  2016-12-20       Impact factor: 5.501

Review 8.  Novel Insights in Systemic Lupus Erythematosus and Atherosclerosis.

Authors:  Vítor Teixeira; Lai-Shan Tam
Journal:  Front Med (Lausanne)       Date:  2018-01-29

9.  Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans In Vivo.

Authors:  Franz Tatzber; Edith Pursch; Ulrike Resch; Roswitha Pfragner; Sandra Holasek; Meinrad Lindschinger; Gerhard Cvirn; Willibald Wonisch
Journal:  Oxid Med Cell Longev       Date:  2017-11-09       Impact factor: 6.543

10.  Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.

Authors:  Uta Hardt; Anders Larsson; Iva Gunnarsson; Robert M Clancy; Michelle Petri; Jill P Buyon; Gregg J Silverman; Elisabet Svenungsson; Caroline Grönwall
Journal:  Arthritis Res Ther       Date:  2018-02-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.